Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus

Journal of NeuroVirology

Volumn 20, Issue 6, 2014, Pages 539-560

  Daep, Carlo Amorin ^a,b   Muñoz Jordán, Jorge L ^c   Eugenin, Eliseo Alberto ^a,b  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Bioterrorism; Brain; Fever; Mosquito; Vaccines

Indexed keywords

ANTIVIRUS AGENT; DENGUE VACCINE; JAPANESE ENCEPHALITIS VACCINE; WEST NILE VACCINE;

AEDES; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; CULEX; DENDRITIC CELL; DENGUE; DENGUE VIRUS; DISEASE CARRIER; FLAVIVIRUS; HUMAN; IMMUNOPATHOGENESIS; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LEUKOCYTE; LIFE CYCLE; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NONHUMAN; REVIEW; VIRAL GENETICS; WEST NILE FEVER; WEST NILE FLAVIVIRUS; AFRICA; ANIMAL; ASIA; DRUG EFFECTS; ENCEPHALITIS, JAPANESE; MOSQUITO; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; TRANSMISSION; VIROLOGY; WEST NILE VIRUS; WESTERN HEMISPHERE;

HEXAPODA; JAPANESE ENCEPHALITIS VIRUS; MOSQUITO-BORNE VIRUSES;

AFRICA; AMERICAS; ANIMALS; ANTIVIRAL AGENTS; ASIA; CULICIDAE; DENGUE; DENGUE VIRUS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS; INSECT VECTORS; PREVALENCE; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84916925340     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0285-z     Document Type: Review

References (237)

1. Ahsan MF, Gore MM (2011) Comparison of immune response generated against Japanese encephalitis virus envelope protein expressed by DNA vaccines under macrophage associated versus ubiquitous expression promoters. Virol J 8:382
2. Alarcon JB, Waine GW, McManus DP (1999) DNA vaccines: technology and application as anti-parasite and anti-microbial agents. Adv Parasitol 42:343–410
3. Aleyas AG, George JA, Han YW, Rahman MM, Kim SJ, Han SB, Kim BS, Kim K, Eo SK (2009) Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J Immunol 183:2462–2474
4. Aleyas AG, Han YW, George JA, Kim B, Kim K, Lee CK, Eo SK (2010) Multifront assault on antigen presentation by Japanese encephalitis virus subverts CD8+ T cell responses. J Immunol 185:1429–1441
5. Amaral DC, Rachid MA, Vilela MC, Campos RD, Ferreira GP, Rodrigues DH, Lacerda-Queiroz N, Miranda AS, Costa VV, Campos MA, Kroon EG, Teixeira MM, Teixeira AL (2011a) Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice. J Neuroinflammation 8:23
6. Amaral DC, Rachid MA, Vilela MC, Campos RD, Ferreira GP, Rodrigues DH, Lacerda-Queiroz N, Miranda AS, Costa VV, Campos MA, Kroon EG, Teixeira MM, Teixeira AL (2011b) Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice. J Neuroinflammation 8:23
7. Anders KL, Nguyet NM, Chau NV, Hung NT, Thuy TT, le Lien B, Farrar J, Wills B, Hien TT, Simmons CP (2011) Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg 84:127–134
8. Anderson KB, Gibbons RV, Thomas SJ, Rothman AL, Nisalak A, Berkelman RL, Libraty DH, Endy TP (2011) Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand. PLoS Negl Trop Dis 5:e1311
9. Appaiahgari MB, Vrati S (2012a) Clinical development of IMOJEV (R)—a recombinant Japanese encephalitis chimeric vaccine (JE-CV). Expert Opin Biol Ther 12:1251–1263
10. Appaiahgari MB, Vrati S (2012b) Clinical development of IMOJEV (R)—a recombinant Japanese encephalitis chimeric vaccine (JE-CV). Expert Opin Biol Ther 12:1251–1263
11. Araujo FM, Brilhante RS, Cavalcanti LP, Rocha MF, Cordeiro RA, Perdigao AC, Miralles IS, Araujo LC, Araujo RM, Lima EG, Sidrim JJ (2011) Detection of the dengue non-structural 1 antigen in cerebral spinal fluid samples using a commercially available enzyme-linked immunosorbent assay. J Virol Methods 177:128–131
12. Araujo F, Nogueira R, Araujo Mde S, Perdigao A, Cavalcanti L, Brilhante R, Rocha M, Vilar DF, Holanda SS, Braga Dde M, Sidrim J (2012) Dengue in patients with central nervous system manifestations, Brazil. Emerg Infect Dis 18:677–679
13. Arroyo J, Miller C, Catalan J, Myers GA, Ratterree MS, Trent DW, Monath TP (2004) ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol 78:12497–12507
14. Ashour J, Laurent-Rolle M, Shi PY, Garcia-Sastre A (2009) NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83:5408–5418
15. Azeredo EL, Neves-Souza PC, Alvarenga AR, Reis SR, Torrentes-Carvalho A, Zagne SM, Nogueira RM, Oliveira-Pinto LM, Kubelka CF (2010) Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology 130:202–216
16. Azevedo AS, Goncalves AJ, Archer M, Freire MS, Galler R, Alves AM (2013) The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue. PLoS One 8:e58357
17. Bai F, Town T, Pradhan D, Cox J, Ashish LM, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E (2007) Antiviral peptides targeting the West Nile virus envelope protein. J Virol 81:2047–2055
18. Beatty ME, Vorndam V, Hunsperger EA, Munoz JL, Clark GG (2005) Travel-associated dengue infections—United States, 2001–2004. Morb Mortal Wkly Rep 54:556–558
19. Beckett CG, Tjaden J, Burgess T, Danko JR, Tamminga C, Simmons M, Wu SJ, Sun P, Kochel T, Raviprakash K, Hayes CG, Porter KR (2011) Evaluation of a prototype dengue-1 DNA vaccine in a phase 1 clinical trial. Vaccine 29:960–968
20. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI (2013) The global distribution and burden of dengue. Nature 496:504–507
21. Bhoopat L, Bhamarapravati N, Attasiri C, Yoksarn S, Chaiwun B, Khunamornpong S, Sirisanthana V (1996a) Immunohistochemical characterization of a new monoclonal antibody reactive with dengue virus-infected cells in frozen tissue using immunoperoxidase technique. Asian Pac J Allergy Immunol launched Allergy Immunol Soc Thail 14:107–113
22. Bhoopat L, Bhamarapravati N, Attasiri C, Yoksarn S, Chaiwun B, Khunamornpong S, Sirisanthana V (1996b) Immunohistochemical characterization of a new monoclonal antibody reactive with dengue virus-infected cells in frozen tissue using immunoperoxidase technique. Asian Pac J Allergy Immunol 14:107–113
23. Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould EA, Grard G, Grimes JM, Hilgenfeld R, Jansson AM, Malet H, Mancini EJ, Mastrangelo E, Mattevi A, Milani M, Moureau G, Neyts J, Owens RJ, Ren J, Selisko B, Speroni S, Steuber H, Stuart DI, Unge T, Bolognesi M (2010) Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res 87:125–148
24. Bray M, Lai CJ (1991) Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc Natl Acad Sci U S A 88:10342–10346
25. Bray M, Men R, Lai CJ (1996) Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. J Virol 70:4162–4166
26. Brehin AC, Mouries J, Frenkiel MP, Dadaglio G, Despres P, Lafon M, Couderc T (2008) Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+ B220-BST-2+ leukocyte population. J Immunol 180:6760–6767
27. Brewoo JN, Kinney RM, Powell TD, Arguello JJ, Silengo SJ, Partidos CD, Huang CY, Stinchcomb DT, Osorio JE (2012) Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice. Vaccine 30:1513–1520
28. Brunkard JM, Robles Lopez JL, Ramirez J, Cifuentes E, Rothenberg SJ, Hunsperger EA, Moore CG, Brussolo RM, Villarreal NA, Haddad BM (2007) Dengue fever seroprevalence and risk factors, Texas–Mexico border, 2004. Emerg Infect Dis 13:1477–1483
29. Buckner CM, Luers AJ, Calderon TM, Eugenin EA, Berman JW (2006) Neuroimmunity and the blood–brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J Neuroimmune Pharm 1:160–181
30. Burke T (1968) Dengue haemorrhagic fever: a pathological study. Trans R Soc Trop Med Hyg 62:682–692
31. Caminade C, Medlock JM, Ducheyne E, McIntyre KM, Leach S, Baylis M, Morse AP (2012) Suitability of European climate for the Asian tiger mosquito Aedes albopictus: recent trends and future scenarios. J R Soc Interface 9:2708–2717
32. Chambers TJ, Nestorowicz A, Mason PW, Rice CM (1999) Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol 73:3095–3101
33. Chambers TJ, Liang Y, Droll DA, Schlesinger JJ, Davidson AD, Wright PJ, Jiang X (2003) Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model. J Virol 77:3655–3668
34. Chao DL, Halstead SB, Halloran ME, Longini IM Jr (2012) Controlling dengue with vaccines in Thailand. PLoS Negl Trop Dis 6:e1876
35. Chappell KJ, Stoermer MJ, Fairlie DP, Young PR (2008) West Nile virus NS2B/NS3 protease as an antiviral target. Curr Med Chem 15:2771–2784
36. Chase AJ, Medina FA, Munoz-Jordan JL (2011) Impairment of CD4+ T cell polarization by dengue virus-infected dendritic cells. J Infect Dis 203:1763–1774
37. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS (2000) Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28:183–188
38. Cheeran MC, Hu S, Sheng WS, Rashid A, Peterson PK, Lokensgard JR (2005) Differential responses of human brain cells to West Nile virus infection. J Neurovirol 11:512–524
39. Chen SP (2012) Molecular phylogenetic and evolutionary analysis of Japanese encephalitis virus in China. Epidemiol Infect 140:1637–1643
40. Chen CJ, Chen JH, Chen SY, Liao SL, Raung SL (2004) Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection. J Virol 78:12107–12119
41. Chu JJ, Ng ML (2003) Characterization of a 105-kDa plasma membrane associated glycoprotein that is involved in West Nile virus binding and infection. Virology 312:458–469
42. Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, Patterson N, Guerrero M, Bennett JW, McGrath S, Ganeshan H, Belmonte M, Farooq F, Abot E, Banania JG, Huang J, Newcomer R, Rein L, Litilit D, Richie NO, Wood C, Murphy J, Sauerwein R, Hermsen CC, McCoy AJ, Kamau E, Cummings J, Komisar J, Sutamihardja A, Shi M, Epstein JE, Maiolatesi S, Tosh D, Limbach K, Angov E, Bergmann-Leitner E, Bruder JT, Doolan DL, King CR, Carucci D, Dutta S, Soisson L, Diggs C, Hollingdale MR, Ockenhouse CF, Richie TL (2013) DNA prime/adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PLoS One 8:e55571
43. Clyde K, Harris E (2006) RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol 80:2170–2182
44. Clyde K, Kyle JL, Harris E (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80:11418–11431
45. Costa SM, Freire MS, Alves AM (2006a) DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus. Vaccine 24:4562–4564
46. Costa SM, Paes MV, Barreto DF, Pinhao AT, Barth OM, Queiroz JL, Armoa GR, Freire MS, Alves AM (2006b) Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence. Vaccine 24:195–205
47. Costa SM, Azevedo AS, Paes MV, Sarges FS, Freire MS, Alves AM (2007) DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. Virology 358:413–423
48. Courageot MP, Catteau A, Despres P (2003) Mechanisms of dengue virus-induced cell death. Adv Virus Res 60:157–186
49. Das S, Basu A (2008) Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation. J Neurochem 106:1624–1636
50. Das S, Mishra MK, Ghosh J, Basu A (2008) Japanese encephalitis virus infection induces IL-18 and IL-1beta in microglia and astrocytes: correlation with in vitro cytokine responsiveness of glial cells and subsequent neuronal death. J Neuroimmunol 195:60–72
51. Davis AM, Hagan KA, Matthews LA, Bajwa G, Gill MA, Gale M Jr, Farrar JD (2008a) Blockade of virus infection by human CD4+ T cells via a cytokine relay network. J Immunol 180:6923–6932
52. Davis MR, Langan JN, Johnson YJ, Ritchie BW, Van Bonn W (2008b) West Nile virus seroconversion in penguins after vaccination with a killed virus vaccine or a DNA vaccine. J Zoo Wildl Med 39:582–589
53. De Burghgraeve T, Kaptein SJ, Ayala-Nunez NV, Mondotte JA, Pastorino B, Printsevskaya SS, de Lamballerie X, Jacobs M, Preobrazhenskaya M, Gamarnik AV, Smit JM, Neyts J (2012) An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro. PLoS One 7:e37244
54. Despres P, Frenkiel MP, Ceccaldi PE, Duarte Dos Santos C, Deubel V (1998) Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J Virol 72:823–829
55. Dharakul T, Kurane I, Bhamarapravati N, Yoksan S, Vaughn DW, Hoke CH, Ennis FA (1994) Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine. J Infect Dis 170:27–33
56. Dikeakos JD, Atkins KM, Thomas L, Emert-Sedlak L, Byeon IJ, Jung J, Ahn J, Wortman MD, Kukull B, Saito M, Koizumi H, Williamson DM, Hiyoshi M, Barklis E, Takiguchi M, Suzu S, Gronenborn AM, Smithgall TE, Thomas G (2010) Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol Biol Cell 21:3279–3292
57. Diniz JA, Da Rosa AP, Guzman H, Xu F, Xiao SY, Popov VL, Vasconcelos PF, Tesh RB (2006) West Nile virus infection of primary mouse neuronal and neuroglial cells: the role of astrocytes in chronic infection. Am J Trop Med Hyg 75:691–696
58. Durbin AP, McArthur JH, Marron JA, Blaney JE, Thumar B, Wanionek K, Murphy BR, Whitehead SS (2006) rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naive adults. Hum Vaccin 2:255–260
59. Durbin AP, Vargas MJ, Wanionek K, Hammond SN, Gordon A, Rocha C, Balmaseda A, Harris E (2008) Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 376:429–435
60. Effler PV, Pang L, Kitsutani P, Vorndam V, Nakata M, Ayers T, Elm J, Tom T, Reiter P, Rigau-Perez JG, Hayes JM, Mills K, Napier M, Clark GG, Gubler DJ (2005) Dengue fever, Hawaii, 2001–2002. Emerg Infect Dis 11:742–749
61. Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B (2002) An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J 21:2757–2768
62. Ehrenfeld E, Modlin J, Chumakov K (2009) Future of polio vaccines. Expert Rev Vaccines 8:899–905
63. Eugenin EA, Berman JW (2003) Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood–brain barrier. Methods 29:351–361
64. Eugenin EA, Berman JW (2007) Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J Neurosci Off J Soc Neurosci 27:12844–12850
65. Eugenin EA, Berman JW (2013) Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystader apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanims. J Neurochem 127(5):644–651
66. Eugenin EA, Gamss R, Buckner C, Buono D, Klein RS, Schoenbaum EE, Calderon TM, Berman JW (2006a) Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol 79:444–452
67. Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW (2006b) CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood–brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 26:1098–1106
68. Eugenin EA, Clements JE, Zink MC, Berman JW (2011) Human immunodeficiency virus infection of human astrocytes disrupts blood–brain barrier integrity by a gap junction-dependent mechanism. J Neurosci Off J Soc Neurosci 31:9456–9465
69. Ferraro B, Morrow MP, Hutnick NA, Shin TH, Lucke CE, Weiner DB (2011) Clinical applications of DNA vaccines: current progress. Clin Infect Dis 53:296–302
70. Filocamo G, Pacini L, Nardi C, Bartholomew L, Scaturro M, Delmastro P, Tramontano A, De Francesco R, Migliaccio G (1999) Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses. J Virol 73:561–575
71. Fink K, Ng C, Nkenfou C, Vasudevan SG, van Rooijen N, Schul W (2009) Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control. Eur J Immunol 39:2809–2821
72. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, Keystone JS, Pandey P, Cetron MS, GeoSentinel Surveillance N (2006) Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354:119–130
73. Gagnon SJ, Zeng W, Kurane I, Ennis FA (1996) Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones. J Virol 70:141–147
74. Geiss BJ, Thompson AA, Andrews AJ, Sons RL, Gari HH, Keenan SM, Peersen OB (2009) Analysis of flavivirus NS5 methyltransferase cap binding. J Mol Biol 385:1643–1654
75. German AC, Myint KS, Mai NT, Pomeroy I, Phu NH, Tzartos J, Winter P, Collett J, Farrar J, Barrett A, Kipar A, Esiri MM, Solomon T (2006) A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg 100:1135–1145
76. Getts DR, Matsumoto I, Muller M, Getts MT, Radford J, Shrestha B, Campbell IL, King NJ (2007) Role of IFN-gamma in an experimental murine model of West Nile virus-induced seizures. J Neurochem 103:1019–1030
77. Getts DR, Terry RL, Getts MT, Muller M, Rana S, Shrestha B, Radford J, Van Rooijen N, Campbell IL, King NJ (2008) Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med 205:2319–2337
78. Ghoshal A, Das S, Ghosh S, Mishra MK, Sharma V, Koli P, Sen E, Basu A (2007) Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55:483–496
79. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM (2005) Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202:1087–1098
80. Graham AS, Pruszynski CA, Hribar LJ, DeMay DJ, Tambasco AN, Hartley AE, Fussell EM, Michael SF, Isern S (2011) Mosquito-associated dengue virus, Key West, Florida, USA, 2010. Emerg Infect Dis 17:2074–2075
81. Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11:480–496
82. Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10:100–103
83. Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrett AD, Monath TP (1999) Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever–Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology 257:363–372
84. Guirakhoo F, Weltzin R, Chambers TJ, Zhang ZX, Soike K, Ratterree M, Arroyo J, Georgakopoulos K, Catalan J, Monath TP (2000) Recombinant chimeric yellow fever–dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol 74:5477–5485
85. Halstead SB (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239:476–481
86. Halstead SB, O'Rourke EJ (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739–741
87. Halstead SB, Thomas SJ (2011) New Japanese encephalitis vaccines: alternatives to production in mouse brain. Expert Rev Vaccines 10:355–364
88. Halstead SB, Lan NT, Myint TT, Shwe TN, Nisalak A, Kalyanarooj S, Nimmannitya S, Soegijanto S, Vaughn DW, Endy TP (2002) Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis 8:1474–1479
89. Hammon WM, Sather GE (1973) Passive immunity for arbovirus infection. I. Artificially induced prophylaxis in man and mouse for Japanese (B) encephalitis. Am J Trop Med Hyg 22:524–534
90. Hansen JE (2006) Avoiding climate change. Science 311:469–470
91. Harris E, Holden KL, Edgil D, Polacek C, Clyde K (2006) Molecular biology of flaviviruses. Novartis Found Symp 277:23–39, discussion 40, 71–3, 251–3
92. Hase T, Dubois DR, Summers PL, Downs MB, Ussery MA (1993) Comparison of replication rates and pathogenicities between the SA14 parent and SA14-14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons. Arch Virol 130:131–143
93. Heinz FX, Stiasny K (2012) Flaviviruses and flavivirus vaccines. Vaccine 30:4301–4306
94. Hennessy S, Liu Z, Tsai TF, Strom BL, Wan CM, Liu HL, Wu TX, Yu HJ, Liu QM, Karabatsos N, Bilker WB, Halstead SB (1996) Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case–control study. Lancet 347:1583–1586
95. Hirsch AJ, Medigeshi GR, Meyers HL, DeFilippis V, Fruh K, Briese T, Lipkin WI, Nelson JA (2005) The Src family kinase c-Yes is required for maturation of West Nile virus particles. J Virol 79:11943–11951
96. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, Imbert P, Pecarere JL, Vergez-Pascal R, Wattre P et al (1993) Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 48:324–331
97. Hober D, Delannoy AS, Benyoucef S, De Groote D, Wattre P (1996a) High levels of sTNFR p75 and TNF alpha in dengue-infected patients. Microbiol Immunol 40:569–573
98. Hober D, Shen L, Benyoucef S, De Groote D, Deubel V, Wattre P (1996b) Enhanced TNF alpha production by monocytic-like cells exposed to dengue virus antigens. Immunol Lett 53:115–120
99. Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z (2013) Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus. Biomaterials 34:3511–3522
100. Hussmann KL, Samuel MA, Kim KS, Diamond MS, Fredericksen BL (2013) Differential replication of pathogenic and nonpathogenic strains of West Nile virus within astrocytes. J Virol 87:2814–2822
101. Imrie A, Zhao Z, Bennett SN, Kitsutani P, Laille M, Effler P (2006) Molecular epidemiology of dengue in the Pacific: introduction of two distinct strains of dengue virus type-1 [corrected] into Hawaii. Ann Trop Med Parasitol 100:327–336
102. Ishikawa T, Wang G, Widman DG, Infante E, Winkelmann ER, Bourne N, Mason PW (2011) Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene. Vaccine 29:7444–7455
103. Issur M, Geiss BJ, Bougie I, Picard-Jean F, Despins S, Mayette J, Hobdey SE, Bisaillon M (2009) The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. RNA 15:2340–2350
104. Jan JT, Chen BH, Ma SH, Liu CI, Tsai HP, Wu HC, Jiang SY, Yang KD, Shaio MF (2000) Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved. J Virol 74:8680–8691
105. Jessie K, Fong MY, Devi S, Lam SK, Wong KT (2004) Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189:1411–1418
106. Johnson BW, Chambers TV, Crabtree MB, Bhatt TR, Guirakhoo F, Monath TP, Miller BR (2002) Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes. Am J Trop Med Hyg 67:260–265
107. Johnson BW, Chambers TV, Crabtree MB, Guirakhoo F, Monath TP, Miller BR (2004) Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction. Am J Trop Med Hyg 70:89–97
108. Kawaguchi I, Sasaki A, Boots M (2003) Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains. Proc Biol Sci 270:2241–2247
109. Khanna N, Agnihotri M, Mathur A, Chaturvedi UC (1991) Neutrophil chemotactic factor produced by Japanese encephalitis virus stimulated macrophages. Clin Exp Immunol 86:299–303
110. Khor CC, Chau TN, Pang J, Davila S, Long HT, Ong RT, Dunstan SJ, Wills B, Farrar J, Van Tram T, Gan TT, Binh NT, le Tri T, le Lien B, Tuan NM, Tham NT, Lanh MN, Nguyet NM, Hieu NT, Van NVCN, Thuy TT, Tan DE, Sakuntabhai A, Teo YY, Hibberd ML, Simmons CP (2011) Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet 43:1139–1141
111. King AD, Nisalak A, Kalayanrooj S, Myint KS, Pattanapanyasat K, Nimmannitya S, Innis BL (1999) B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian J Trop Med Public Health 30:718–728
112. King NJ, Shrestha B, Kesson AM (2003) Immune modulation by flaviviruses. Adv Virus Res 60:121–155
113. Kliks SC, Nimmanitya S, Nisalak A, Burke DS (1988) Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38:411–419
114. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS (1989) Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40:444–451
115. Krishnamurti C, Kalayanarooj S, Cutting MA, Peat RA, Rothwell SW, Reid TJ, Green S, Nisalak A, Endy TP, Vaughn DW, Nimmannitya S, Innis BL (2001) Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 65:840–847
116. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717–725
117. Kulkarni R, Sapkal G, Gore M (2012) Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice. Virus Res 170:118–125
118. Kumar R, Tripathi S, Tambe JJ, Arora V, Srivastava A, Nag VL (2008) Dengue encephalopathy in children in Northern India: clinical features and comparison with non dengue. J Neurol Sci 269:41–48
119. Kurane I, Innis BL, Nisalak A, Hoke C, Nimmannitya S, Meager A, Ennis FA (1989) Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest 83:506–513
120. Kurane I, Brinton MA, Samson AL, Ennis FA (1991a) Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol 65:1823–1828
121. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA (1991b) Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 88:1473–1480
122. Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, Rockx B, Liu W, Ashour J, Shupert WL, Holbrook MR, Barrett AD, Mason PW, Bloom ME, Garcia-Sastre A, Khromykh AA, Best SM (2010) The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol 84:3503–3515
123. Lee CJ, Liao CL, Lin YL (2005) Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. J Virol 79:8388–8399
124. Lee DW, Choe YJ, Kim JH, Song KM, Cho H, Bae GR, Lee JK (2012) Epidemiology of Japanese encephalitis in South Korea, 2007–2010. Int J Infect Dis 16:e448–e452
125. Lescar J, Luo D, Xu T, Sampath A, Lim SP, Canard B, Vasudevan SG (2008) Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from dengue virus as a target. Antiviral Res 80:94–101
126. Leyssen P, De Clercq E, Neyts J (2000) Perspectives for the treatment of infections with Flaviviridae. Clin Microbiol Rev 13:67–82, Table of contents
127. Liao M, Sanchez-San Martin C, Zheng A, Kielian M (2010) In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J Virol 84:5730–5740
128. Lima DM, de Paula SO, Franca RF, Palma PV, Morais FR, Gomes-Ruiz AC, de Aquino MT, da Fonseca BA (2011) A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection. Vaccine 29:831–838
129. Lin YL, Huang YL, Ma SH, Yeh CT, Chiou SY, Chen LK, Liao CL (1997) Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol 71:5227–5235
130. Lin YW, Wang KJ, Lei HY, Lin YS, Yeh TM, Liu HS, Liu CC, Chen SH (2002) Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol 76:12242–12249
131. Lin RJ, Chang BL, Yu HP, Liao CL, Lin YL (2006) Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol 80:5908–5918
132. Lindenbach BD, Pragai BM, Montserret R, Beran RK, Pyle AM, Penin F, Rice CM (2007) The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication. J Virol 81:8905–8918
133. Lindsey NP, Staples JE, Lehman JA, Fischer M (2010) Surveillance for human West Nile virus disease—United States, 1999–2008. MMWR Surveill Summ 59:1–17
134. Liu X, Yu Y, Li M, Liang G, Wang H, Jia L, Dong G (2011) Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China. Vaccine 29:2127–2130
135. Liu S, Li X, Chen Z, Chen Y, Zhang Q, Liao Y, Zhou J, Ke X, Ma L, Xiao J, Wu Y, Zheng X, Li J, Chen Q (2013) Comparison of genomic and amino acid sequences of eight Japanese encephalitis virus isolates from bats. Arch Virol 158:2543–2552
136. Lobigs M, Larena M, Alsharifi M, Lee E, Pavy M (2009) Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus. J Virol 83:2436–2445
137. Lu H, Xu XF, Gao N, Fan DY, Wang J, An J (2013) Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice. Mol Immunol 54:109–114
138. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL (2004) Dengue viral infections. Postgrad Med J 80:588–601
139. Manns MP, Bourliere M, Benhamou Y, Pol S, Bonacini M, Trepo C, Wright D, Berg T, Calleja JL, White PW, Stern JO, Steinmann G, Yong CL, Kukolj G, Scherer J, Boecher WO (2011) Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection. J Hepatol 54:1114–1122
140. Mathew A, West K, Kalayanarooj S, Gibbons RV, Srikiatkhachorn A, Green S, Libraty D, Jaiswal S, Rothman AL (2011) B-cell responses during primary and secondary dengue virus infections in humans. J Infect Dis 204:1514–1522
141. Mathur A, Bharadwaj M, Kulshreshtha R, Rawat S, Jain A, Chaturvedi UC (1988) Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol 69:423–432
142. Mazzon M, Jones M, Davidson A, Chain B, Jacobs M (2009) Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 200:1261–1270
143. Medigeshi GR, Lancaster AM, Hirsch AJ, Briese T, Lipkin WI, Defilippis V, Fruh K, Mason PW, Nikolich-Zugich J, Nelson JA (2007) West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J Virol 81:10849–10860
144. Mentor NA, Kurane I (1997) Dengue virus infection of human T lymphocytes. Acta Virol 41:175–176
145. Miagostovich MP, dos Santos FB, de Araujo ES, Dias J, Schatzmayr HG, Nogueira RM (1997a) Diagnosis of dengue by using reverse transcriptase-polymerase chain reaction. Mem Inst Oswaldo Cruz 92:595–599
146. Miagostovich MP, Ramos RG, Nicol AF, Nogueira RM, Cuzzi-Maya T, Oliveira AV, Marchevsky RS, Mesquita RP, Schatzmayr HG (1997b) Retrospective study on dengue fatal cases. Clin Neuropathol 16:204–208
147. Mishra MK, Ghosh D, Duseja R, Basu A (2009) Antioxidant potential of minocycline in Japanese encephalitis virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death. Neurochem Int 54:464–470
148. Mohammed H, Ramos M, Armstrong J, Munoz-Jordan J, Arnold-Lewis KO, Ayala A, Clark GG, Tull ES, Beatty ME (2010a) An outbreak of dengue fever in St. Croix (US Virgin Islands), 2005. PLoS One 5:e13729
149. Mohammed HP, Ramos MM, Rivera A, Johansson M, Munoz-Jordan JL, Sun W, Tomashek KM (2010b) Travel-associated dengue infections in the United States, 1996 to 2005. J Travel Med 17:8–14
150. Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F (1999) Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine 17:1869–1882
151. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9:921–927
152. Mota J, Rico-Hesse R (2011) Dengue virus tropism in humanized mice recapitulates human dengue fever. PLoS One 6:e20762
153. Mousson L, Dauga C, Garrigues T, Schaffner F, Vazeille M, Failloux AB (2005) Phylogeography of Aedes (Stegomyia) aegypti (L.) and Aedes (Stegomyia) albopictus (Skuse) (Diptera: Culicidae) based on mitochondrial DNA variations. Genet Res 86:1–11
154. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A (2003) Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100:14333–14338
155. Nathanson N, Cole GA (1970) Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res 16:397–448
156. Nazareth B, Levin J, Johnson H, Begg N (1994) Systemic allergic reactions to Japanese encephalitis vaccines. Vaccine 12:666
157. Nguyen TH, Nguyen TL, Lei HY, Lin YS, Le BL, Huang KJ, Lin CF, Do QH, Vu TQ, Lam TM, Yeh TM, Huang JH, Liu CC, Halstead SB (2005) Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am J Trop Med Hyg 72:370–374
158. Noisakran S, Dechtawewat T, Avirutnan P, Kinoshita T, Siripanyaphinyo U, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N (2008) Association of dengue virus NS1 protein with lipid rafts. J Gen Virol 89:2492–2500
159. Obeid S, Printsevskaya SS, Olsufyeva EN, Dallmeier K, Durantel D, Zoulim F, Preobrazhenskaya MN, Neyts J, Paeshuyse J (2011) Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics. J Antimicrob Chemother 66:1287–1294
160. Ogata A, Nagashima K, Hall WW, Ichikawa M, Kimura-Kuroda J, Yasui K (1991) Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. J Virol 65:880–886
161. Oh W, Yang MR, Lee EW, Park KM, Pyo S, Yang JS, Lee HW, Song J (2006) Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. J Biol Chem 281:30166–30174
162. Ohtaki E, Matsuishi T, Hirano Y, Maekawa K (1995) Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains). J Neurol Neurosurg Psychiatry 59:316–317
163. Okada M, Kita Y, Nakajima T, Hashimoto S, Nakatani H, Nishimatsu S, Nishida Y, Kanamaru N, Kaneda Y, Takamori Y, McMurray D, Tan EV, Cang ML, Saunderson P, Dela Cruz EC (2012) The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis. Hum Vaccin Immunother 9
164. Olaleye OD, Omilabu SA, Ilomechina EN, Fagbami AH (1990) A survey for haemagglutination-inhibiting antibody to West Nile virus in human and animal sera in Nigeria. Comp Immunol Microbiol Infect Dis 13:35–39
165. Paessler S, Walker DH (2013) Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 8:411–440
166. Palmer DR, Sun P, Celluzzi C, Bisbing J, Pang S, Sun W, Marovich MA, Burgess T (2005) Differential effects of dengue virus on infected and bystander dendritic cells. J Virol 79:2432–2439
167. Pang T, Cardosa MJ, Guzman MG (2007) Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever–dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85:43–45
168. Paranjape SM, Harris E (2007) Y box-binding protein-1 binds to the dengue virus 3′-untranslated region and mediates antiviral effects. J Biol Chem 282:30497–30508
169. Parquet MC, Kumatori A, Hasebe F, Morita K, Igarashi A (2001) West Nile virus-induced bax-dependent apoptosis. FEBS Lett 500:17–24
170. Pauvolid-Correa A, Morales MA, Levis S, Figueiredo LT, Couto-Lima D, Campos Z, Nogueira MF, da Silva EE, Nogueira RM, Schatzmayr HG (2011) Neutralising antibodies for West Nile virus in horses from Brazilian Pantanal. Mem Inst Oswaldo Cruz 106:467–474
171. Peiris JS, Amerasinghe FP, Amerasinghe PH, Ratnayake CB, Karunaratne SH, Tsai TF (1992) Japanese encephalitis in Sri Lanka—the study of an epidemic: vector incrimination, porcine infection and human disease. Trans R Soc Trop Med Hyg 86:307–313
172. Pekosz A, Phillips J, Pleasure D, Merry D, Gonzalez-Scarano F (1996) Induction of apoptosis by La Crosse virus infection and role of neuronal differentiation and human bcl-2 expression in its prevention. J Virol 70:5329–5335
173. Petersen LR, Marfin AA (2005) Shifting epidemiology of Flaviviridae. J Travel Med 12(Suppl 1):S3–S11
174. Phung BC, Yeni P (2011) Darunavir: an effective protease inhibitor for HIV-infected patients. Expert Rev Anti-Infect Ther 9:631–643
175. Plesner AM (2003) Allergic reactions to Japanese encephalitis vaccine. Immunol Allergy Clin N Am 23:665–697
176. Plesner AM, Ronne T (1997) Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine 15:1239–1243
177. Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K (1981) Persistence of neutralizing antibody 30–35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 59:895–900
178. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S, Mokashi N, Vaidya D, Shah PS, Cecilia D (2010) Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 5:e8709
179. Proudfoot AE, Wells TN, Clapham PR (1999) Chemokine receptors–future therapeutic targets for HIV? Biochem Pharmacol 57:451–463
180. Pugachev KV, Guirakhoo F, Trent DW, Monath TP (2003) Traditional and novel approaches to flavivirus vaccines. Int J Parasitol 33:567–582
181. Pugachev KV, Guirakhoo F, Mitchell F, Ocran SW, Parsons M, Johnson BW, Kosoy OL, Lanciotti RS, Roehrig JT, Trent DW, Monath TP (2004) Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool. Am J Trop Med Hyg 71:639–645
182. Pulmanausahakul R, Roytrakul S, Auewarakul P, Smith DR (2011) Chikungunya in Southeast Asia: understanding the emergence and finding solutions. Int J Inf Dis IJID Off Publ Int Soc Inf Dis 15:e671–e676
183. Qing M, Yang F, Zhang B, Zou G, Robida JM, Yuan Z, Tang H, Shi PY (2009) Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein. Antimicrob Agents Chemother 53:3226–3235
184. Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203:413–424
185. Radke EG, Gregory CJ, Kintziger KW, Sauber-Schatz EK, Hunsperger EA, Gallagher GR, Barber JM, Biggerstaff BJ, Stanek DR, Tomashek KM, Blackmore CG (2012) Dengue outbreak in Key West, Florida, USA, 2009. Emerg Infect Dis 18:135–137
186. Rahmstorf S, Cazenave A, Church JA, Hansen JE, Keeling RF, Parker DE, Somerville RC (2007) Recent climate observations compared to projections. Science 316:709
187. Ramirez LA, Arango T, Boyer J (2013) Therapeutic and prophylactic DNA vaccines for HIV-1. Expert Opin Biol Ther 13:563–573
188. Ramos C, Sanchez G, Pando RH, Baquera J, Hernandez D, Mota J, Ramos J, Flores A, Llausas E (1998) Dengue virus in the brain of a fatal case of hemorrhagic dengue fever. J Neurovirol 4:465–468
189. Ramos MM, Mohammed H, Zielinski-Gutierrez E, Hayden MH, Lopez JL, Fournier M, Trujillo AR, Burton R, Brunkard JM, Anaya-Lopez L, Banicki AA, Morales PK, Smith B, Munoz-Jordan JL, Waterman SH (2008) Epidemic dengue and dengue hemorrhagic fever at the Texas–Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am J Trop Med Hyg 78:364–369
190. Raung SL, Chen SY, Liao SL, Chen JH, Chen CJ (2005) Tyrosine kinase inhibitors attenuate Japanese encephalitis virus-induced neurotoxicity. Biochem Biophys Res Commun 327:399–406
191. Raung SL, Chen SY, Liao SL, Chen JH, Chen CJ (2007) Japanese encephalitis virus infection stimulates Src tyrosine kinase in neuron/glia. Neurosci Lett 419:263–268
192. Rauscher S, Flamm C, Mandl CW, Heinz FX, Stadler PF (1997) Secondary structure of the 3′-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities. RNA 3:779–791
193. Ravi V, Desai AS, Shenoy PK, Satishchandra P, Chandramuki A, Gourie-Devi M (1993) Persistence of Japanese encephalitis virus in the human nervous system. J Med Virol 40:326–329
194. Ravi V, Parida S, Desai A, Chandramuki A, Gourie-Devi M, Grau GE (1997) Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 51:132–136
195. Reed KD, Meece JK, Henkel JS, Shukla SK (2003) Birds, migration and emerging zoonoses: West Nile virus, lyme disease, influenza A and enteropathogens. Clin Med Res 1:5–12
196. Restrepo BN, Isaza DM, Salazar CL, Ramirez R, Ospina M, Alvarez LG (2008a) Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue. Rev Soc Bras Med Trop 41:6–10
197. Restrepo BN, Ramirez RE, Arboleda M, Alvarez G, Ospina M, Diaz FJ (2008b) Serum levels of cytokines in two ethnic groups with dengue virus infection. Am J Trop Med Hyg 79:673–677
198. Rigau-Perez JG, Vorndam AV, Clark GG (2001) The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994–1995. Am J Trop Med Hyg 64:67–74
199. Roberts TK, Eugenin EA, Lopez L, Romero IA, Weksler BB, Couraud PO, Berman JW (2012a) CCL2 disrupts the adherens junction: implications for neuroinflammation. Lab Investig 92:1213–1233
200. Roberts TK, Eugenin EA, Lopez L, Romero IA, Weksler BB, Couraud PO, Berman JW (2012b) CCL2 disrupts the adherens junction: implications for neuroinflammation. Lab Investig J Tech Methods Pathol 92:1213–1233
201. Rodenhuis-Zybert IA, Wilschut J, Smit JM (2010) Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci 67:2773–2786
202. Roe K, Kumar M, Lum S, Orillo B, Nerurkar VR, Verma S (2012a) West Nile virus-induced disruption of the blood–brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virology 93:1193–1203
203. Roe K, Kumar M, Lum S, Orillo B, Nerurkar VR, Verma S (2012b) West Nile virus-induced disruption of the blood–brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virol 93:1193–1203
204. Rothman AL (2009) T lymphocyte responses to heterologous secondary dengue virus infections. Ann N Y Acad Sci 1171(Suppl 1):E36–E41
205. Sabin AB (1952) Research on dengue during World War II. Am J Trop Med Hyg 1:30–50
206. Samuel MA, Diamond MS (2006) Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80:9349–9360
207. Sarkari NB, Thacker AK, Barthwal SP, Mishra VK, Prapann S, Srivastava D, Sarkari M (2012a) Japanese encephalitis (JE) part II: 14 years' follow-up of survivors. J Neurol 259:58–69
208. Sarkari NB, Thacker AK, Barthwal SP, Mishra VK, Prapann S, Srivastava D, Sarkari M (2012b) Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics. J Neurol 259:47–57
209. Schioler KL, Samuel M, Wai KL (2007) Vaccines for preventing Japanese encephalitis. Cochrane Database Syst Rev CD004263
210. Schmidt AG, Lee K, Yang PL, Harrison SC (2012) Small-molecule inhibitors of dengue-virus entry. PLoS Pathog 8:e1002627
211. Schneeweiss A, Chabierski S, Salomo M, Delaroque N, Al-Robaiy S, Grunwald T, Burki K, Liebert UG, Ulbert S (2011) A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. Vaccine 29:6352–6357
212. Screaton G, Mongkolsapaya J (2006) T cell responses and dengue haemorrhagic fever. Novartis Found Symp 277:164–171, discussion 171–6, 251–3
213. Sharp TM, Pillai P, Hunsperger E, Santiago GA, Anderson T, Vap T, Collinson J, Buss BF, Safranek TJ, Sotir MJ, Jentes ES, Munoz-Jordan JL, Arguello DF (2012) A cluster of dengue cases in American missionaries returning from Haiti, 2010. Am J Trop Med Hyg 86:16–22
214. Simmons CP, Farrar JJ, Nguyen VV, Wills B (2012) Dengue. N Engl J Med 366:1423–1432
215. Singh A, Kulshreshtha R, Mathur A (2000) An enzyme immunoassay for detection of Japanese encephalitis virus-induced chemotactic cytokine. J Biosci 25:47–55
216. Soares CN, Faria LC, Peralta JM, de Freitas MR, Puccioni-Sohler M (2006) Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci 249:19–24
217. Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ (2000) Neurological manifestations of dengue infection. Lancet 355:1053–1059
218. Spindler KR, Hsu TH (2012a) Viral disruption of the blood–brain barrier. Trends Microbiol 20:282–290
219. Spindler KR, Hsu TH (2012b) Viral disruption of the blood–brain barrier. Trends Microbiol 20:282–290
220. Srikiatkhachorn A, Wichit S, Gibbons RV, Green S, Libraty DH, Endy TP, Ennis FA, Kalayanarooj S, Rothman AL (2012) Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status. PLoS One 7:e51335
221. Stahla-Beek HJ, April DG, Saeedi BJ, Hannah AM, Keenan SM, Geiss BJ (2012) Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme. J Virol 86:8730–8739
222. Su HL, Liao CL, Lin YL (2002) Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response. J Virol 76:4162–4171
223. Sutter RW, Prevots DR, Cochi SL (2000) Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States. Pediatr Clin N Am 47:287–308
224. Swarup V, Ghosh J, Das S, Basu A (2008) Tumor necrosis factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis. Neurochem Int 52:1310–1321
225. Tomashek KM, Rivera A, Munoz-Jordan JL, Hunsperger E, Santiago L, Padro O, Garcia E, Sun W (2009) Description of a large island-wide outbreak of dengue in Puerto Rico, 2007. Am J Trop Med Hyg 81:467–474
226. Tung WH, Tsai HW, Lee IT, Hsieh HL, Chen WJ, Chen YL, Yang CM (2010) Japanese encephalitis virus induces matrix metalloproteinase-9 in rat brain astrocytes via NF-kappaB signalling dependent on MAPKs and reactive oxygen species. Br J Pharmacol 161:1566–1583
227. Umareddy I, Tang KF, Vasudevan SG, Devi S, Hibberd ML, Gu F (2008) Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines. J Gen Virol 89:3052–3062
228. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, Zhuang X, Smit JM (2008) Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4:e1000244
229. Verma S, Lo Y, Chapagain M, Lum S, Kumar M, Gurjav U, Luo H, Nakatsuka A, Nerurkar VR (2009) West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in vitro blood–brain barrier. Virology 385:425–433
230. Williams DW, Eugenin EA, Calderon TM, Berman JW (2012) Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol 91:401–415
231. Wills MR, Sil BK, Cao JX, Yu YX, Barrett AD (1992) Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area. Vaccine 10:861–872
232. Xin YY, Ming ZG, Peng GY, Jian A, Min LH (1988) Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 39:214–217
233. Yu IM, Zhang W, Holdaway HA, Li L, Kostyuchenko VA, Chipman PR, Kuhn RJ, Rossmann MG, Chen J (2008) Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319:1834–1837
234. Zanotto PM, Gould EA, Gao GF, Harvey PH, Holmes EC (1996) Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A 93:548–553
235. Zhang Y, Zhang W, Ogata S, Clements D, Strauss JH, Baker TS, Kuhn RJ, Rossmann MG (2004) Conformational changes of the flavivirus E glycoprotein. Structure 12:1607–1618
236. Zhou J, Stohlman SA, Hinton DR, Marten NW (2003) Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J Immunol 170:3331–3336
237. Zybert IA, van der Ende-Metselaar H, Wilschut J, Smit JM (2008) Functional importance of dengue virus maturation: infectious properties of immature virions. J Gen Virol 89:3047–3051